Literature DB >> 24504399

Pediatric requirements in Europe stymie help for hemophilia.

Flora Peyvandi1, Frits R Rosendaal2, Brian O'Mahony3, Pier Mannuccio Mannucci4.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24504399     DOI： 10.1038/nm0214-117

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  3 in total

1.  The increasing prevalence of haemophilia.

Authors:  F R Rosendaal; E Briët
Journal:  Thromb Haemost       Date:  1990-02-19       Impact factor: 5.249

2.  Phase 3 study of recombinant factor IX Fc fusion protein in hemophilia B.

Authors:  Jerry S Powell; K John Pasi; Margaret V Ragni; Margareth C Ozelo; Leonard A Valentino; Johnny N Mahlangu; Neil C Josephson; David Perry; Marilyn J Manco-Johnson; Shashikant Apte; Ross I Baker; Godfrey C Chan; Nicolas Novitzky; Raymond S Wong; Snejana Krassova; Geoffrey Allen; Haiyan Jiang; Alison Innes; Shuanglian Li; Lynda M Cristiano; Jaya Goyal; Jurg M Sommer; Jennifer A Dumont; Karen Nugent; Gloria Vigliani; Aoife Brennan; Alvin Luk; Glenn F Pierce
Journal:  N Engl J Med       Date:  2013-12-04       Impact factor: 91.245

3.  Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A.

Authors:  Johnny Mahlangu; Jerry S Powell; Margaret V Ragni; Pratima Chowdary; Neil C Josephson; Ingrid Pabinger; Hideji Hanabusa; Naresh Gupta; Roshni Kulkarni; Patrick Fogarty; David Perry; Amy Shapiro; K John Pasi; Shashikant Apte; Ivan Nestorov; Haiyan Jiang; Shuanglian Li; Srividya Neelakantan; Lynda M Cristiano; Jaya Goyal; Jurg M Sommer; Jennifer A Dumont; Nigel Dodd; Karen Nugent; Gloria Vigliani; Alvin Luk; Aoife Brennan; Glenn F Pierce
Journal:  Blood       Date:  2013-11-13       Impact factor: 22.113
  3 in total
  4 in total

1.  The importance and challenge of pediatric trials of hemophilia drugs.

Authors:  Robin Huff
Journal:  Nat Med       Date:  2014-05       Impact factor: 53.440

2.  The importance and challenge of pediatric trials of hemophilia drugs.

Authors:  Dirk Mentzer; Emilie Desfontaine; Paolo A Tomasi
Journal:  Nat Med       Date:  2014-05       Impact factor: 53.440

3.  Reply to: The importance and challenge of pediatric trials of hemophilia drugs.

Authors:  Flora Peyvandi; Frits R Rosendaal; Brian O'Mahony; Pier Mannuccio Mannucci
Journal:  Nat Med       Date:  2014-05       Impact factor: 53.440

4.  The influence of the European paediatric regulation on marketing authorisation of orphan drugs for children.

Authors:  Annemarie Rosan Kreeftmeijer-Vegter; Anthonius de Boer; Roselinda H van der Vlugt-Meijer; Peter J de Vries
Journal:  Orphanet J Rare Dis       Date:  2014-08-05       Impact factor: 4.123
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.